Extended follow-up of stage A1 carcinoma of prostate

Ian M. Thompson, Eric J. Zeidman

Research output: Contribution to journalArticlepeer-review

30 Scopus citations


The prognosis and proper treatment of Stage A1 carcinoma of the prostate remain unsettled. We report on 60 patients with Stage A1 prostate cancer (less than 5 foci of well-differentiated tumor) diagnosed between 1960 and 1980. Mean duration of follow-up was 7.5 years with a range of one to twenty years. Three patients (5%) suffered disease progression at two, five, and nineteen years of follow-up, and all died of their tumor. Thirty-four patients (56%) have died of other causes. Number of tumor foci had no correlation with chance of disease progression. Extended follow-up of these patients suggests that the vast majority with Stage A1 carcinoma of the prostate will not suffer from morbidity or mortality of the disease but will more commonly succumb to other intervening disease processes.

Original languageEnglish (US)
Pages (from-to)455-458
Number of pages4
Issue number6
StatePublished - Jun 1989

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Extended follow-up of stage A1 carcinoma of prostate'. Together they form a unique fingerprint.

Cite this